ABSTRACT

It is an accepted part of business life, especially in multinational pharmaceutical companies, for executives to travel great distances to attend meetings, including medical, financial, manufacturing, sales and management conferences, and board meetings. Now everyone must weigh up the consequences of such travel. Why?